TFFP Annual Operating Expenses
$21.89 M
-$9.90 M-31.14%
31 December 2023
Summary:
As of January 23, 2025, TFFP annual total operating expenses is $21.89 million, with the most recent change of -$9.90 million (-31.14%) on December 31, 2023. During the last 3 years, it has risen by +$3.20 million (+17.12%). TFFP annual operating expenses is now -31.14% below its all-time high of $31.80 million, reached on December 31, 2022.TFFP Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TFFP Quarterly Operating Expenses
$3.69 M
-$924.70 K-20.05%
30 September 2024
Summary:
As of January 23, 2025, TFFP quarterly total operating expenses is $3.69 million, with the most recent change of -$924.70 thousand (-20.05%) on September 30, 2024. Over the past year, it has dropped by -$924.70 thousand (-20.05%). TFFP quarterly operating expenses is now -63.47% below its all-time high of $10.10 million, reached on December 31, 2021.TFFP Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TFFP Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -31.1% | -20.1% |
| 3 y3 years | +17.1% | -50.0% |
| 5 y5 years | - | -50.0% |
TFFP Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.1% | at low | -63.5% | at low |
| 5 y | 5-year | -31.1% | +82.6% | -63.5% | at low |
| alltime | all time | -31.1% | >+9999.0% | -63.5% | +508.5% |
TFF Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.69 M(-20.0%) |
| June 2024 | - | $4.61 M(-23.0%) |
| Mar 2024 | - | $5.99 M(+25.0%) |
| Dec 2023 | $21.89 M(-31.1%) | $4.79 M(+4.0%) |
| Sept 2023 | - | $4.61 M(-13.9%) |
| June 2023 | - | $5.35 M(-25.0%) |
| Mar 2023 | - | $7.14 M(-3.3%) |
| Dec 2022 | $31.80 M(+0.0%) | $7.38 M(+1.4%) |
| Sept 2022 | - | $7.28 M(-16.8%) |
| June 2022 | - | $8.75 M(+4.4%) |
| Mar 2022 | - | $8.38 M(-17.0%) |
| Dec 2021 | $31.79 M | $10.10 M(+16.4%) |
| Sept 2021 | - | $8.68 M(+69.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $5.11 M(-35.3%) |
| Mar 2021 | - | $7.90 M(+33.5%) |
| Dec 2020 | $18.69 M(+55.9%) | $5.92 M(+16.5%) |
| Sept 2020 | - | $5.08 M(+32.2%) |
| June 2020 | - | $3.84 M(-0.3%) |
| Mar 2020 | - | $3.85 M(-18.2%) |
| Dec 2019 | $11.99 M(+6612.0%) | $4.71 M(+64.5%) |
| Sept 2019 | - | $2.86 M(+29.7%) |
| June 2019 | - | $2.21 M(+0.3%) |
| Mar 2019 | - | $2.20 M(+263.4%) |
| Sept 2018 | - | $606.10 K |
| Dec 2017 | $178.60 K(-96.9%) | - |
| Sept 2013 | $5.68 M(-26.5%) | - |
| Sept 2012 | $7.73 M | - |
FAQ
- What is TFF Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for TFF Pharmaceuticals?
- What is TFF Pharmaceuticals annual operating expenses year-on-year change?
- What is TFF Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for TFF Pharmaceuticals?
- What is TFF Pharmaceuticals quarterly operating expenses year-on-year change?
What is TFF Pharmaceuticals annual total operating expenses?
The current annual operating expenses of TFFP is $21.89 M
What is the all time high annual operating expenses for TFF Pharmaceuticals?
TFF Pharmaceuticals all-time high annual total operating expenses is $31.80 M
What is TFF Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, TFFP annual total operating expenses has changed by -$9.90 M (-31.14%)
What is TFF Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of TFFP is $3.69 M
What is the all time high quarterly operating expenses for TFF Pharmaceuticals?
TFF Pharmaceuticals all-time high quarterly total operating expenses is $10.10 M
What is TFF Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, TFFP quarterly total operating expenses has changed by -$924.70 K (-20.05%)